CLASS IDrug recall · Reported 7 Feb 2018 · FDA Enforcement Report
Power V, 200mg, 10-Grain, labeling is in foreign language recalled
A&H Focal is recalling Power V, 200mg, 10-Grain, labeling is in foreign language, distributed in New Jersey, New York. The recall was initiated on 7 Mar 2017 and the FDA has classified it as Class I.
Check your package
Lot, batch or date codesAll Lots
Quantity recalledunknown
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Marked Without An Approved NDA/ANDA: FDA analysis found these products to contain sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making these products unapproved drugs for which safety and efficacy have not been establish and therefore, subject to recall.
Products marketed as supplements sometimes contain undeclared prescription drug ingredients such as sildenafil or sibutramine. These can interact dangerously with other medicines.
Product as listed by the FDA
Power V8 Viagra tablets, 200mg, 10-Grain bottle, labeling is in foreign language
Where it was distributed
NY and NJ through six retail stores named "Asian Food Markets"
Marked Without An Approved NDA/ANDA: FDA analysis found these products to contain sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making these products unapproved drugs for which safety and efficacy have not been establish and therefore, subject to recall.
Which lots are affected?
All Lots
Where was it sold?
NY and NJ through six retail stores named "Asian Food Markets"
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class I mean?
Class I is the most serious FDA recall category: there is a reasonable probability that using the product will cause serious health consequences or death.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.